BACKGROUND/AIM: The in vivo effect of abiraterone on bone mineral density (BMD) in addition to androgen deprivation therapy was examined using a murine model. MATERIALS AND METHODS: The mice were separated into the following groups: control, abiraterone, castration, and castration+abiraterone. The percentage change in the ratio of bone to tissue volume (BV/TV), number of osteoblasts and osteoclasts, and the serum level of bone markers were compared on day 21. RESULTS: The BV/TV ratio of the abiraterone, castration, and castration+abiraterone groups was lower than that of the control group. However, the change in the BV/TV ratio in the castration+abiraterone group was not significantly different from that in the castration group. There was no significant difference in the serum TRAP5b level and the number of osteoclasts and osteoblasts between the castration+abiraterone and the castration groups. CONCLUSION: The addition of abiraterone to castration did not affect BMD in the murine model. Copyright
BACKGROUND/AIM: The in vivo effect of abiraterone on bone mineral density (BMD) in addition to androgen deprivation therapy was examined using a murine model. MATERIALS AND METHODS: The mice were separated into the following groups: control, abiraterone, castration, and castration+abiraterone. The percentage change in the ratio of bone to tissue volume (BV/TV), number of osteoblasts and osteoclasts, and the serum level of bone markers were compared on day 21. RESULTS: The BV/TV ratio of the abiraterone, castration, and castration+abiraterone groups was lower than that of the control group. However, the change in the BV/TV ratio in the castration+abiraterone group was not significantly different from that in the castration group. There was no significant difference in the serum TRAP5b level and the number of osteoclasts and osteoblasts between the castration+abiraterone and the castration groups. CONCLUSION: The addition of abiraterone to castration did not affect BMD in the murine model. Copyright
Authors: Matthew Smith; Chris Parker; Fred Saad; Kurt Miller; Bertrand Tombal; Quan Sing Ng; Martin Boegemann; Vsevolod Matveev; Josep Maria Piulats; Luis Eduardo Zucca; Oleg Karyakin; Go Kimura; Nobuaki Matsubara; William Carlos Nahas; Franco Nolè; Eli Rosenbaum; Axel Heidenreich; Yoshiyuki Kakehi; Amily Zhang; Heiko Krissel; Michael Teufel; Junwu Shen; Volker Wagner; Celestia Higano Journal: Lancet Oncol Date: 2019-02-06 Impact factor: 41.316
Authors: E Carton; G Noe; O Huillard; L Golmard; J Giroux; A Cessot; N E B Saidu; M Peyromaure; M Zerbib; C Narjoz; J Guibourdenche; A Thomas; M Vidal; F Goldwasser; B Blanchet; J Alexandre Journal: Eur J Cancer Date: 2016-12-24 Impact factor: 9.162
Authors: Stephanie T Page; William J Bremner; Richard V Clark; Mark A Bush; Hui Zhi; Ralph B Caricofe; Peter M Smith; John K Amory Journal: J Androl Date: 2007-12-12
Authors: M R Sydes; M R Spears; M D Mason; N W Clarke; D P Dearnaley; J S de Bono; G Attard; S Chowdhury; W Cross; S Gillessen; Z I Malik; R Jones; C C Parker; A W S Ritchie; J M Russell; R Millman; D Matheson; C Amos; C Gilson; A Birtle; S Brock; L Capaldi; P Chakraborti; A Choudhury; L Evans; D Ford; J Gale; S Gibbs; D C Gilbert; R Hughes; D McLaren; J F Lester; A Nikapota; J O'Sullivan; O Parikh; C Peedell; A Protheroe; S M Rudman; R Shaffer; D Sheehan; M Simms; N Srihari; R Strebel; S Sundar; S Tolan; D Tsang; M Varughese; J Wagstaff; M K B Parmar; N D James Journal: Ann Oncol Date: 2018-05-01 Impact factor: 32.976
Authors: Cindy Strehl; Johannes W J Bijlsma; Maarten de Wit; Maarten Boers; Nele Caeyers; Maurizio Cutolo; Bhaskar Dasgupta; William G Dixon; Rinie Geenen; Tom W J Huizinga; Alison Kent; Annette Ladefoged de Thurah; Joachim Listing; Xavier Mariette; David W Ray; Hans U Scherer; Raphaèle Seror; Cornelia M Spies; Simon Tarp; Dieter Wiek; Kevin L Winthrop; Frank Buttgereit Journal: Ann Rheum Dis Date: 2016-03-01 Impact factor: 19.103
Authors: Penelope D Ottewell; Ning Wang; Joshua Meek; C Anne Fowles; Peter I Croucher; Colby L Eaton; Ingunn Holen Journal: Endocr Relat Cancer Date: 2014-07-22 Impact factor: 5.678